In addition, Xue et al. [9] stated that CYTL1 acts as a tumor suppressor and maintains intracellular metabolic homeostasis in tumors, although Wang et al. [14] initially explored the expression patterns of CYTL1 in breast, prostate, lung, and gastric cancers through bioinformatics. The gene discussed is CYTL1; the disease is neoplasm.